APDP - Associação Protectora dos Diabéticos, Portugal

Similar documents
Central Manchester University Hospitals NHS Foundation Trust, UK

The Centre for Disease Prevention and Control, Latvia

Hospital Carlos Haya. Malaga, Spain

Hospital Universitario de Getafe (Getafe Universitary Hospital), Spain

National Center for Tumor Diseases (NCT) Heidelberg, Germany

Ministry for Health, the Elderly and Community Care, Malta

Scandinavian Ear Reconstruction Centre, Dept of Plastic and Reconstructive Surgery, SWEDEN

European Society of Cardiology, France

INSTITUTE OF CHILD HEALTH, Greece

RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain

Radboud University Nijmegen Medical Centre, department of Neurology, Netherlands

SERVICIO DE NEUROCIRUGÍA PEDIÁTRICA. HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Spain

Castilla y leon Regional Health Service (Gerencia Regional de Salud de Castilla y León)

Department of Medical Genetics, Medical School, University of Athens, Greece

Cystic Fibrosis Europe (CFE), Germany

Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands

Schoen Kliniken group, Schoen Klinik Hamburg Eilbek, Dept. of neurology and. neurorehabilitation, Germany

Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC), Latvia

VSOP, Lupus Netherlands

European Haemophilia Consortium

UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

ERN board of Member States

WORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT. 1 EU 3rd HEALTH PROGRAMME

European Reference Networks (ERN) Guide for patient advocates

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Spreading Excellence and Widening Participation in Horizon 2020

ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

European Reference Networks: strategic value for the Member States. Perspective of France

116 Help Lines for Rare Diseases

Legal and financial issues Evaluation process

BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)

ehealth in caring for people with multimorbidity in European countries

Presenting the European Investment Advisory Hub Annual Forum of the EUSDR, 2015 Ulm. European Investment Advisory Hub 1

2ème Conférence sur les Réseaux Européens de Référence. 8-9 octobre 2015, Lisbonne. Table ronde ministérielle (8 octobre 12 :15 13 :00)

Summary of a Survey on the Europe 2020 Flagship Initiative Innovation Union. Executive Summary

The Seventh Framework Programme for candidate and potential candidate countries European Regional Economic Forum Nova Gorica, 30 May 2007

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Simona Bovha, CPCM European Investment Bank. European Investment Advisory Hub

EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks

Call for Nominations. CARLOS V European Award

S. Tziaferi. President FOHNEU Assistant Professor in Community Nursing Dep. of Nursing University of Peloponnese

Implementing the 3rd Health Programme. Ingrid Keller Coordinator Health Programme Consumer, Health and Food Executive Agency

A European workforce for call centre services. Construction industry recruits abroad

ERC Grant Schemes. Horizon 2020 European Union funding for Research & Innovation

ERN Assessment Manual for Applicants

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Report on the interim evaluation of the «Daphne III Programme »

Copernicus Incubation Programme

European network of paediatric research (EnprEMA)

EUROPEAN COMMISSION HEALTH AND CONSUMER PROTECTION DG. Directorate C: Public Health and Risk Assessment Unit C2 - Health information

Background paper. Cross-border healthcare in the EU

Introduction to ibmg. Marco Varkevisser Director of Education

A short paper for ENVI & IMCO MEPs Two solutions to improve recognition of specialisms in the Chapter III professions

Jean Monnet support to associations

European Solidarity Corps

National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

Evolution of Nursing in Europe

Building the Europe of Knowledge

EPF Workshops on Cross-Border Healthcare 1st Stop: Croatia Meeting Report

Developing a European Registry for Rare Anaemias

Table Of Content. Strengthening voluntary cooperation between Member States to improve the health of EU citizens... 2 Summary... 3 Work Package...

BLUE TECHNOLOGY. Claus Schultze (DG MARE, E1) Victoria Beaz Hidalgo (EASME, A3 EMFF) #bluegrowth

European Investment Advisory Hub

Do terms like FP6, CORDIS, Specific Programme, Call for

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

Call for the expression of interest Selection of six model demonstrator regions to receive advisory support from the European Cluster Observatory

Info Session Webinar Joint Qualifications in Vocational Education and Training Call for proposals EACEA 27/ /10/2017

Spreading Excellence and Widening Participation in Horizon 2020 TWINNING

Online Consultation on the Future of the Erasmus Mundus Programme. Summary of Results

Council, 25 September 2014

Commissioning Policy (WM12) Patients Changing Responsible Commissioner. Version 2 February 2012

Supportive Care Roundtable

1. Outline the benefits bi-national working arrangements bring to the following:

MARIE SKŁODOWSKA-CURIE ACTIONS. Individual Fellowships (IF) Date: in 12 pts. David WIZEL Research Executive Agency. 18 March 2016 Split

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

Delegations will find attached document EEAS 02246/8/14 REV 8.

FP7 IDEAS The European Research Council

FP7: Marie Curie Actions

Assessment of Erasmus+ Sports

Annex 3 Information and Communication Requirements EEA and Norway Grants

Horizon 2020 LEIT-Space

EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations

Amending the Certificate of Current Professional Status template

EUROPEAN COMMISSION DIRECTORATE-GENERAL REGIONAL AND URBAN POLICY

Job Description. Clinical Nurse Specialist in Breast care. An overview of Breast Cancer Services at the UPMC Beacon Hospital.

S2 and Directive routes: guidance for commissioners

VASCERN 1st Annual Seminar Paris, France October 2017

Consultation: Transformation Health and Care in the Digital Single

The ERC funding strategy

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

EUREKA and Eurostars: Instruments for international R&D cooperation

Factsheet 3: The General Block Exemption Regulation (GBER) in Interreg Baltic Sea Region

ANNEX I TO VIII ANNEX I. Health Programme Work Programme for 2017

Erasmus Mundus José Gutiérrez Fernández Erasmus Mundus Programme Coordinator EACEA

FUNDING NATURAL HERITAGE PROJECTS IN SCOTLAND LIFE+ NATURE AND BIODIVERISTY

QUICK REFERENCE TO CALDICOTT & THE DATA PROTECTION ACT 1998 PRINCIPLES

H2020 Work Programme : Spreading Excellence and Widening Participation Call: H2020-TWINN-2015: Twinning Frequently Asked Questions (FAQ)

Transcription:

APDP - Associação Protectora dos Diabéticos, Portugal 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: Please indicate level: 1. Respondent Profile Patient organisation/association National level organisation Please indicate for what the administration is responsible: 1.1.1. Other (please specify): 1.2 Please indicate the name of your organisation or centre: APDP - Associação Protectora dos Diabéticos de Portugal 1.3 Please indicate the country where your organsation/centre is located/has its headquarters or main representative office in Europe: PT 1. Please indicate the number of EU Member States and EEA countries (rway, Iceland, Lichtenstein) and accessing country (Croatia) in which your organisation conducts business/is represented: 1 1.5 If need be, can we contact you by e-mail to obtain further information on your submission? 1.5.1 Please provide an e-mail address where we can contact you: diabetes.int@apdp.pt 1.6 Please provide us with a contact person (incl jobtitle and daytime phone number): 1.7 Please provide additional contact details if needed: Yes Prof. João Filipe Raposo 2. Involvement of your organisation in the matter of centres of excellence/reference (COE) and healthcare networks in highly specialised healthcare (HSHC).

2.1 How would you describe your organisation's knowledge of CoE and HSHC? 2.1.1 Space for further comments: 2.2. What aspects or domains related to the topic of CoE and HSHC would correspond to your organisation's key knowledge? (cross any that applies) Poor Highly specialised healthcare provision Management and organisational aspects of highly specialized healthcare Social aspects Professional performance, clinical practice, quality and safety of specialized healthcare 2.2.1. Space for further comments: 2.3 Is highly specialised healthcare a priority in your organisation's strategies and work plans? 2.3.1 Space for further comments: 2.. What specific field of healthcare services/specialities are most relevant for your centre/organisation's field of work? Please specify: Very high Medical/Surgical speciality ophthalmological surgery for people with diabetes 2.5. Has your organisation/centre been directly involved in the design or assessment of professional standards and criteria related with highly specialised healthcare? 2.5.1 Please describe your role in such actions/projects: 2.6. Has your organisation been involved in projects/activities supported by the Commission in relation with HSHC or professional and technical criteria/standards in highly specialised healthcare? opinion

2.7. Do you have concrete examples based on your own organisation's experience or could you provide us with references or links to documents related with professional criteria and standards in highly specialised healthcare/coe or HSHC (e.g. quality criteria, guidelines, consensus documents)? 2.7.1 Space for further comments: 2.13. What is the scope of the network? 2.1. Which kind of network? 2.1.1 Space for further comments: 2.15. Would you be interested in applying to the process to be considered Centre of Excellence of the future European Reference Network? (1 = not interested at all, 5 = very interested) 2.15.1 Space for further comments: 3. Proposed criteria for ERN (scope, general and specific criteria) 3.1 Criteria related with diseases or conditions in order to be considered under the scope of the ERN 3.1.1. Need of highly specialised healthcare 5 3.1.1.1. Complexity of the diagnosis and treatment 5 3.1.1.2. High cost of treatment and resources 3 3.1.1.3. Need of advanced/highly specialised medical equipment or infrastructures 3.1.2. Need of particular concentration of expertise and resources 3 3.1.2.1. Rare expertise/need of concentration of cases

3.1.2.2. Low prevalence/incidence/number of cases 3.1.2.3. Evaluated experiences of Member States 3 3.1.3. Based on high-quality, accessible and cost-effective healthcare 3.1.3.1. Evidence of the safety and favourable risk-benefit analysis 3.1.3.2. Feasibility and evidence of the value and potential positive outcome (clinical) 3.1.. Do you recommend any additional criteria or option that would effectively address the issue? 3.1.5. Would you prioritise or suggest any concrete disesase or group of diseases to be addressed by the future ERN according to the above criteria? 3.1.5.1 Explain your proposal in free text: Diabetes/NCDs Yes 3.2. General criteria of the centres wishing to join a European Reference Network 3.2.1. Organisation and management 3.2.2. Patients empowerment and centered care 5 3.2.3. Patient care, clinical tools and health technology assessment 5 3.2.. Quality, patient safety and evaluation framework policies 5 3.2.5. Business continuity, contingency planning and response capacity 3.2.6. Information systems, technology and e-health tools and applications

3.2.7. Overall framework and capacity for research and training 3.2.8. Specific commitment of the management/direction of the centre/hospital to ensure a full and active participation in the ERN 3.2.9. Do you recommend any additional option that would effectively address the issue? 3.2.9.1. Space for further comments: 3.3. Specific criteria regarding the areas of expertise 3.3.1. Competence, experience and good outcomes and care 5 3.3.2. Specific resources and organisation: 3.3.2.1. Human resources 3.3.2.2. Team/centre organisation 5 3.3.2.3. Structural conditions 3.3.2.. Specific equipment 3 3.3.2.5. Presence and coordination with other required complementary units or services 3.3.3. Patient care pathways, protocols and clinical guidelines in the field of expertise 3.3.. External coordination, care management and follow-up of patients 3.3.5. Research, training, health technology assessment in the field of expertise

3.3.6. Specific information systems 3.3.7. Do you recommend any additional criteria or option that would effectively address the issue? 3.3.7.1. Space for further comments: further comments